TY - JOUR AU - Colcher, A. AU - Simuni, T. PY - 1999 DA - 1999// TI - Parkinson’s disease and parkinsonian syndromes: clinical manifestations of Parkinson’s disease JO - Med Clin NA VL - 83 ID - Colcher1999 ER - TY - JOUR AU - Edwards, L. L. AU - Pfeiffer, R. F. AU - Quigley, E. M. M. AU - Hofman, R. AU - Balluff, M. PY - 1991 DA - 1991// TI - Gastrointestinal symptoms in Parkinson’s disease JO - Mov Disord VL - 6 UR - https://doi.org/10.1002/mds.870060211 DO - 10.1002/mds.870060211 ID - Edwards1991 ER - TY - JOUR AU - Bassotti, G. AU - Maggio, D. AU - Battaglia, E. AU - Giulietti, O. AU - Spinotti, F. AU - Reboldi, G. AU - Serra, A. M. AU - Emmanuelli, G. AU - Chiaroni, G. PY - 2000 DA - 2000// TI - Manometric investigation of anorectal function in early and late stage Parkinson’s disease JO - J Neurol Neurosurg Psychiatr VL - 68 UR - https://doi.org/10.1136/jnnp.68.6.768 DO - 10.1136/jnnp.68.6.768 ID - Bassotti2000 ER - TY - JOUR AU - Kaye, J. AU - Gage, H. AU - Kimber, A. AU - Storey, L. AU - Trend, P. PY - 2006 DA - 2006// TI - Excess burden of constipation in Parkinson’s disease: a pilot study JO - Mov Disord VL - 21 UR - https://doi.org/10.1002/mds.20942 DO - 10.1002/mds.20942 ID - Kaye2006 ER - TY - JOUR AU - Müller-Lissner, S. AU - Rykx, A. AU - Kerstens, R. AU - Vandeplassche, L. PY - 2010 DA - 2010// TI - A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation Neurogastroenterology and motility JO - J Eur Gastr Motil Soc VL - 22 UR - https://doi.org/10.1111/j.1365-2982.2010.01533.x DO - 10.1111/j.1365-2982.2010.01533.x ID - Müller-Lissner2010 ER - TY - JOUR AU - Garnett, W. R. PY - 1996 DA - 1996// TI - Gastrointestinal dysmotility and central nervous system disorders: use of cisapride in patients with Parkinson’s disease JO - Consult Pharm VL - 11 ID - Garnett1996 ER - TY - JOUR AU - Contin, M. AU - Martinelli, P. PY - 2010 DA - 2010// TI - Pharmacokinetics of levodopa JO - J Neurol VL - 257 UR - https://doi.org/10.1007/s00415-010-5728-8 DO - 10.1007/s00415-010-5728-8 ID - Contin2010 ER - TY - JOUR AU - Cedarbaum, J. M. PY - 1989 DA - 1989// TI - The promise and limitations of controlledrelease oral levodopa administration JO - Clin Neuropharmacol VL - 12 UR - https://doi.org/10.1097/00002826-198906000-00001 DO - 10.1097/00002826-198906000-00001 ID - Cedarbaum1989 ER - TY - JOUR AU - Contin, M. AU - Riva, R. AU - Albani, F. AU - Baruzzi, A. PY - 1996 DA - 1996// TI - Pharmacokinetic optimisation in the treatment of Parkinson’s disease JO - Clin Pharmacokinet VL - 30 UR - https://doi.org/10.2165/00003088-199630060-00004 DO - 10.2165/00003088-199630060-00004 ID - Contin1996 ER - TY - JOUR AU - Contin, M. AU - Riva, R. AU - Martinelli, P. AU - Albani, F. AU - Avoni, P. AU - Baruzzi, A. PY - 2001 DA - 2001// TI - Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic aproach JO - Ther Drug Monitor VL - 23 UR - https://doi.org/10.1097/00007691-200112000-00005 DO - 10.1097/00007691-200112000-00005 ID - Contin2001 ER - TY - JOUR AU - Nutt, J. G. AU - Woodward, W. R. PY - 1986 DA - 1986// TI - Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients JO - Neurology VL - 36 UR - https://doi.org/10.1212/WNL.36.6.739 DO - 10.1212/WNL.36.6.739 ID - Nutt1986 ER - TY - JOUR AU - Nutt, J. G. AU - Woodward, W. R. AU - Hammerstad, J. P. AU - Carter, J. H. AU - Anderson, J. L. PY - 1984 DA - 1984// TI - The “on-off” phenomenon in Parkinson’s disease: relation to levodopa absorption and transport JO - New England J Med VL - 310 UR - https://doi.org/10.1056/NEJM198402233100802 DO - 10.1056/NEJM198402233100802 ID - Nutt1984 ER - TY - JOUR AU - Crevoisier, C. AU - Zerr, P. AU - Calvi-Gries, F. AU - Nilsen, T. PY - 2003 DA - 2003// TI - Effects of food on the pharmacokinetics of levodopa in a dual-release formulation JO - Eur J Pharm Biopharm VL - 55 UR - https://doi.org/10.1016/S0939-6411(02)00124-8 DO - 10.1016/S0939-6411(02)00124-8 ID - Crevoisier2003 ER - TY - JOUR AU - Nutt, J. G. AU - Fellman, J. H. PY - 1984 DA - 1984// TI - Pharmacokinetics of levodopa JO - Clin Neuropharmacol VL - 7 UR - https://doi.org/10.1097/00002826-198403000-00002 DO - 10.1097/00002826-198403000-00002 ID - Nutt1984 ER - TY - CHAP AU - Gibaldi, M. AU - Perrier, D. PY - 1982 DA - 1982// TI - Multicompartment models BT - Pharmacokinetics PB - Marcel Dekker CY - New York ID - Gibaldi1982 ER - TY - JOUR AU - Kaakkola, S. AU - Männistö, P. T. AU - Nissinen, E. AU - Vuorela, A. AU - Mäntylä, R. PY - 2009 DA - 2009// TI - The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa JO - Acta Neurol Scand VL - 72 UR - https://doi.org/10.1111/j.1600-0404.1985.tb00888.x DO - 10.1111/j.1600-0404.1985.tb00888.x ID - Kaakkola2009 ER - TY - JOUR AU - Liang, L. AU - Din, S. AU - Chih-Yen, C. AU - Jiing-Chyuan, L. AU - Full-Young, C. AU - Shou-Dong, L. AU - Hang-Chang, W. PY - 2004 DA - 2004// TI - Impaired gastric myoelectrical activity in patients with Parkinson’s disease and effect of levodopa treatment JO - Dig Dis Sci VL - 49 UR - https://doi.org/10.1023/B:DDAS.0000030083.50003.07 DO - 10.1023/B:DDAS.0000030083.50003.07 ID - Liang2004 ER - TY - JOUR AU - Krösser, S. AU - Neugebauera, R. AU - Chassardb, D. AU - Kovara, A. PY - 2007 DA - 2007// TI - Investigation of the impact of sarizotan on the pharmacokinetics of levodopa JO - Biopharm Drug Dispos VL - 28 UR - https://doi.org/10.1002/bdd.558 DO - 10.1002/bdd.558 ID - Krösser2007 ER - TY - JOUR AU - Baruzzi, A. AU - Contin, M. AU - Riva, R. AU - Procaccianti, G. AU - Albani, F. AU - Tonello, C. AU - Zoni, E. AU - Martinelli, P. PY - 1987 DA - 1987// TI - Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients JO - Clin Neuropharmacol VL - 10 UR - https://doi.org/10.1097/00002826-198712000-00004 DO - 10.1097/00002826-198712000-00004 ID - Baruzzi1987 ER - TY - JOUR AU - Wade, D. N. AU - Mearrick, P. T. AU - Birkett, D. J. AU - Morris, J. PY - 1974 DA - 1974// TI - Variability of L-dopa absorption in man JO - Aust N Z J Med VL - 4 UR - https://doi.org/10.1111/j.1445-5994.1974.tb03162.x DO - 10.1111/j.1445-5994.1974.tb03162.x ID - Wade1974 ER - TY - JOUR AU - Mearrick, P. T. AU - Wade, D. N. AU - Birkett, D. J. AU - Morris, J. PY - 1974 DA - 1974// TI - Metoclopramide, gastric emptying and L-dopa absorption JO - Aust N Z J Med VL - 4 UR - https://doi.org/10.1111/j.1445-5994.1974.tb03163.x DO - 10.1111/j.1445-5994.1974.tb03163.x ID - Mearrick1974 ER - TY - JOUR AU - Evans, M. A. AU - Triggs, E. J. AU - Broe, G. A. AU - Saines, N. PY - 1980 DA - 1980// TI - Systemic availability of orally administered L-dopa in the elderly Parkinson patient JO - Eur J Clin Pharmacol VL - 17 UR - https://doi.org/10.1007/BF00561903 DO - 10.1007/BF00561903 ID - Evans1980 ER - TY - JOUR AU - Rodríguez-Morán, M. AU - Guerrero-Romero, F. AU - Lazcano-Burciaga, G. PY - 1998 DA - 1998// TI - Lipid- and glucose-lowering efficacy of Plantago psyllium in type II diabetes JO - J Diab Complicat VL - 12 UR - https://doi.org/10.1016/S1056-8727(98)00003-8 DO - 10.1016/S1056-8727(98)00003-8 ID - Rodríguez-Morán1998 ER - TY - JOUR AU - Brown, L. AU - Rosner, B. AU - Willett, W. W. AU - Sacks, F. M. PY - 1999 DA - 1999// TI - Cholesterol-lowering effects of dietary fiber: a meta-analysis JO - Am J Clin Nutr VL - 69 ID - Brown1999 ER - TY - JOUR AU - Anderson, J. W. AU - Baird, P. AU - Davis, R. H. AU - Ferreri, S. AU - Knudtson, M. AU - Koraym, A. AU - Waters, V. AU - Williams, C. L. PY - 2009 DA - 2009// TI - Health benefits of dietary fiber JO - Nutr Rev VL - 67 UR - https://doi.org/10.1111/j.1753-4887.2009.00189.x DO - 10.1111/j.1753-4887.2009.00189.x ID - Anderson2009 ER - TY - JOUR AU - Nyholm, D. PY - 2006 DA - 2006// TI - Pharmacokinetic optimisation in the treatment of Parkinson’s Disease: an update JO - Clin Pharmacokinet VL - 45 UR - https://doi.org/10.2165/00003088-200645020-00001 DO - 10.2165/00003088-200645020-00001 ID - Nyholm2006 ER - TY - JOUR AU - Deleu, D. AU - Northway, M. G. AU - Hanssens, Y. PY - 2002 DA - 2002// TI - Clinical pharmacokinetic and pharmacodynamics properties of drugs used in the treatment of Parkinson’s disease JO - Clin Pharm VL - 41 UR - https://doi.org/10.2165/00003088-200241040-00003 DO - 10.2165/00003088-200241040-00003 ID - Deleu2002 ER - TY - JOUR AU - Nutt, J. G. PY - 1987 DA - 1987// TI - On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics JO - Ann Neurol VL - 22 UR - https://doi.org/10.1002/ana.410220415 DO - 10.1002/ana.410220415 ID - Nutt1987 ER - TY - JOUR AU - Djaldetti, R. AU - Koren, M. AU - Ziv, I. AU - Achiron, A. AU - Melamed, E. PY - 1995 DA - 1995// TI - Effect of cisapride on response fluctuations in Parkinson’s disease JO - Mov Disor VL - 10 UR - https://doi.org/10.1002/mds.870100113 DO - 10.1002/mds.870100113 ID - Djaldetti1995 ER - TY - JOUR AU - Fernandez, N. AU - Carriedo, D. AU - Sierra, M. AU - Diez, M. J. AU - Sahagun, A. AU - Calle, A. AU - Gonzalez, A. AU - Garcia, J. J. PY - 2005 DA - 2005// TI - Hydrosoluble fiber (Plantago ovata husk) and levodopa II: experimental study of the pharmacokinetic interaction in the presence of carbidopa JO - Eur Neuropsychopharmacol VL - 15 UR - https://doi.org/10.1016/j.euroneuro.2005.01.006 DO - 10.1016/j.euroneuro.2005.01.006 ID - Fernandez2005 ER - TY - JOUR AU - Garcia, J. J. AU - Fernandez, N. AU - Carriedo, D. AU - Diez, M. J. AU - Sahagun, A. AU - Gonzalez, A. AU - Calle, A. AU - Sierra, M. PY - 2005 DA - 2005// TI - Hydrosoluble fiber (Plantago ovata husk) and levodopa I: experimental study of the pharmacokinetic interaction JO - Eur Neuropsychopharmacol VL - 15 UR - https://doi.org/10.1016/j.euroneuro.2005.01.005 DO - 10.1016/j.euroneuro.2005.01.005 ID - Garcia2005 ER - TY - JOUR AU - Diez, M. J. AU - Garcia, J. J. AU - Prieto, C. AU - Fernandez, N. AU - Sahagun, A. AU - Sierra, M. PY - 2008 DA - 2008// TI - The hydrosoluble fiber Plantago ovata husk improves levodopa (with carbidopa) bioavailability after repeated administration JO - J Neurol Sci VL - 271 UR - https://doi.org/10.1016/j.jns.2008.03.007 DO - 10.1016/j.jns.2008.03.007 ID - Diez2008 ER - TY - JOUR AU - García, J. J. AU - Fernández, N. AU - Calle, A. P. AU - Diez, M. J. AU - Sahagún, A. AU - Sierra, M. PY - 2009 DA - 2009// TI - Effects of Plantago ovata husk on levodopa (with carbidopa) bioavailability in rabbits with autonomic gastrointestinal disorders JO - Drug Metab Dispos VL - 37 UR - https://doi.org/10.1124/dmd.108.026229 DO - 10.1124/dmd.108.026229 ID - García2009 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/296/prepub UR - http://www.biomedcentral.com/1472-6882/14/296/prepub ID - ref34 ER -